275 related articles for article (PubMed ID: 36191626)
1. Role of ADAM and ADAMTS disintegrin and metalloproteinases in normal pregnancy and preeclampsia.
Qu H; Khalil RA
Biochem Pharmacol; 2022 Dec; 206():115266. PubMed ID: 36191626
[TBL] [Abstract][Full Text] [Related]
2. Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.
Lin C; He H; Cui N; Ren Z; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H165-H180. PubMed ID: 31834839
[TBL] [Abstract][Full Text] [Related]
3. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
4. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
Yang H; Khalil RA
Adv Pharmacol; 2022; 94():255-363. PubMed ID: 35659374
[TBL] [Abstract][Full Text] [Related]
5. Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.
Li W; Cui N; Mazzuca MQ; Mata KM; Khalil RA
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H491-H507. PubMed ID: 28626073
[TBL] [Abstract][Full Text] [Related]
6. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
Shah DA; Khalil RA
Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
[TBL] [Abstract][Full Text] [Related]
7. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
Qu H; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
[TBL] [Abstract][Full Text] [Related]
8. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.
Chen J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():87-165. PubMed ID: 28662830
[TBL] [Abstract][Full Text] [Related]
10. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
[TBL] [Abstract][Full Text] [Related]
11. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Chen J; Ren Z; Zhu M; Khalil RA
Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
Possomato-Vieira JS; Khalil RA
Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
[TBL] [Abstract][Full Text] [Related]
14. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
Sharma D; Singh NK
Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
[TBL] [Abstract][Full Text] [Related]
15. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.
Li W; Mata KM; Mazzuca MQ; Khalil RA
Biochem Pharmacol; 2014 Jun; 89(3):370-85. PubMed ID: 24704473
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.
Sheppard SJ; Khalil RA
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):33-52. PubMed ID: 20041838
[TBL] [Abstract][Full Text] [Related]
17. TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats.
Ren Z; Cui N; Zhu M; Khalil RA
Biochem Pharmacol; 2021 Nov; 193():114790. PubMed ID: 34600915
[TBL] [Abstract][Full Text] [Related]
18. Role of proteases in dysfunctional placental vascular remodelling in preeclampsia.
Gutiérrez JA; Gómez I; Chiarello DI; Salsoso R; Klein AD; Guzmán-Gutiérrez E; Toledo F; Sobrevia L
Biochim Biophys Acta Mol Basis Dis; 2020 Feb; 1866(2):165448. PubMed ID: 30954558
[TBL] [Abstract][Full Text] [Related]
19. Spiral, uterine artery doppler and placental ultrasound in relation to preeclampsia.
de Ganzo Suárez T; de Paco Matallana C; Plasencia W
Best Pract Res Clin Obstet Gynaecol; 2024 Feb; 92():102426. PubMed ID: 38039843
[TBL] [Abstract][Full Text] [Related]
20. The Elsevier Trophoblast Research Award Lecture: Importance of metzincin proteases in trophoblast biology and placental development: a focus on ADAM12.
Aghababaei M; Beristain AG
Placenta; 2015 Apr; 36 Suppl 1():S11-9. PubMed ID: 25589360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]